Equities
  • Price (USD)36.27
  • Today's Change0.00 / 0.00%
  • Shares traded0.00
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Oct 19 2022.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

About the company

Ramsay Health Care Limited is an Australia-based healthcare services company. The Company operates through four segments: Asia Pacific, UK, France, and Nordics. Its businesses include Global, Ramsay Australia, Ramsay Sante, Ramsay United Kingdom, Ramsay Sime Darby, and Elysium Healthcare. Its Global business delivers health care services to more than 532 facilities in 10 countries. Ramsay Australia has about 72 private hospitals and day surgery units in Australia. Ramsay Sante is a private care provider in Europe, operating specialist clinics and primary care units in about 350 locations across five countries in Europe. Ramsay United Kingdom has a network of about 34 acute hospitals and day procedure centers. Ramsay Sime Darby operates three hospitals in Indonesia, three hospitals and a nursing college in Malaysia and one day surgery in Hong Kong. Elysium Healthcare provides a range of mental health care in specialist hospitals, residential settings, and community-based homes.

  • Revenue in AUD (TTM)13.21bn
  • Net income in AUD256.90m
  • Incorporated1975
  • Employees86.00k
  • Location
    Ramsay Health Care LtdLevel 7, Tower B,, 7 Westbourne StreetST LEONARDS 2065AustraliaAUS
  • Phone+61 29433-3444
  • Fax+61 29220-1001
  • Websitehttps://www.ramsayhealth.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
RHC:ASX since
announced
Transaction
value
Elysium Healthcare LtdDeal completed13 Dec 202113 Dec 2021Deal completed-6.66%1.03bn
Data delayed at least 20 minutes, as of Nov 28 2022 05:10 GMT.
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.